Towards tailored and targeted adherence assessment to optimise asthma management

npj Primary Care Respiratory Medicine

Volumn 25, Issue , 2015, Pages

  Van Boven, Job F M ^a   Trappenburg, Jaap C A ^b   Van Der Molen, Thys ^c   Chavannes, Niels H ^d  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; DISEASE CONTROL; FEEDBACK SYSTEM; HUMAN; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT PREFERENCE; REVIEW; SELF CARE; DISEASE MANAGEMENT; PERSONALIZED MEDICINE;

ANTIASTHMATIC AGENT;

ANTI-ASTHMATIC AGENTS; ASTHMA; DISEASE MANAGEMENT; HUMANS; MEDICATION ADHERENCE; PRECISION MEDICINE;

EID: 84937459355     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2015.46     Document Type: Review

References (64)

1. Heaney LG, Horne R. Non-adherence in difficult asthma: time to take it seriously. Thorax 2012; 67: 268-270.
2. World Health OrganizationAdherence to long-term therapies - evidence for action 2003. http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf (Accessed 20 November 2014).
3. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011; 105: 930-938.
4. Murphy AC, Proeschal A, Brightling CE, Wardlaw AJ, Pavord I, Bradding P et al. The relationship between clinical outcomes and medication adherence in difficult-tocontrol asthma. Thorax 2012; 67: 751-753.
5. Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114: 1288-1293.
6. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004; 4: 191-195.
7. Morton RW, Everard ML, Elphick HE. Adherence in childhood asthma: the elephant in the room. Arch Dis Child 2014; 99: 949-953.
8. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994; 149: S69-S76, discussion S77-S78.
9. Sumino K, Cabana MD. Medication adherence in asthma patients. Curr Opin Pulm Med 2013; 19: 49-53.
10. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006; 130: 65S-72S.
11. Charles C, Ninot G, Sultan S. Patients' illness perceptions and adherence to treatment with inhaled corticosteroids in asthma. Rev Mal Respir 2011; 28: 626-635.
12. DiMatteo MR. Enhancing patient adherence to medical recommendations. JAMA 1994; 271: 79.
13. Levy ML, Hardwell A, McKnight E, Holmes J. Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J 2013; 22: 406-411.
14. Hardwell A, Barber V, Hargadon T, McKnight E, Holmes J, Levy ML. Technique training does not improve the ability of most patients to use pressurised metereddose inhalers (pMDIs). Prim Care Respir J 2011; 20: 92-96.
15. Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, Lapidus J et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med 2010; 181: 566-577.
16. British Thoracic Society/Scottish Intercollegiate Guideline Network. British guideline on the management of asthma. http://www.sign.ac.uk (Accessed 10 February 2015).
17. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. http://www.ginasthma.org (Accessed 30 October 2014).
18. Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P et al. Selfmanagement education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003; (1): CD001117.
19. Ring N, Jepson R, Hoskins G, Wilson C, Pinnock H, Sheikh A et al. Understanding what helps or hinders asthma action plan use: a systematic review and synthesis of the qualitative literature. Patient Educ Couns 2011; 85: e131-e143.
20. Wiener-Ogilvie S, Pinnock H, Huby G, Sheikh A, Partridge MR, Gillies J. Do practices comply with key recommendations of the British Asthma Guideline? If not, why not? Prim Care Respir J 2007; 16: 369-377.
21. Yin HS, Gupta RS, Tomopoulos S, Wolf MS, Mendelsohn AL, Antler L et al. Readability, suitability, and characteristics of asthma action plans: examination of factors that may impair understanding. Pediatrics 2013; 131: e116-e126.
22. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994; 105: 111-116.
23. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005; 50: 1360-1374, discussion 1374-1375.
24. Cohen JL, Mann DM, Wisnivesky JP, Home R, Leventhal H, Musumeci-Szabo TJ et al. Assessing the validity of self-reported medication adherence among innercity asthmatic adults: the Medication Adherence Report Scale for Asthma. Ann Allergy Asthma Immunol 2009; 103: 325-331.
25. Patel M, Perrin K, Pritchard A, Williams M, Wijesinghe M, Weatherall M et al. Accuracy of patient self-report as a measure of inhaled asthma medication use. Respirology 2013; 18: 546-552.
26. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-497.
27. Corrigan CJ. Asthma therapy: there are guidelines, and then there is real life. Prim Care Respir J 2011; 20: 13-14.
28. Jentzsch NS, Camargos PA. Methods of assessing adherence to inhaled corticosteroid therapy in children and adolescents: adherence rates and their implications for clinical practice. J Bras Pneumol 2008; 34: 614-621.
29. Heiner MM. Key barriers to optimal management of adult asthma in Australia: physician and patient perspectives. Curr Med Res Opin 2007; 23: 1799-1807.
30. Chan AH, Reddel HK, Apter A, Eakin M, Riekert K, Foster JM. Adherence monitoring and e-health: how clinicians and researchers can use technology to promote inhaler adherence for asthma. J Allergy Clin Immunol Pract 2013; 1: 446-454.
31. Patel M, Pilcher J, Travers J, Perrin K, Shaw D, Black P et al. Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial. J Allergy Clin Immunol Pract 2013; 1: 83-91.
32. D'Arcy S, MacHale E, Seheult J, Holmes MS, Hughes C, Sulaiman I et al. A method to assess adherence in inhaler use through analysis of acoustic recordings of inhaler events. PLoS One 2014; 9: e98701.
33. Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest 2002; 121: 871-876.
34. Gong H Jr, Simmons MS, Clark VA, Tashkin DP. Metered-dose inhaler usage in subjects with asthma: comparison of Nebulizer Chronolog and daily diary recordings. J Allergy Clin Immunol 1988; 82: 5-10.
35. Propeller Health. http://www.propellerhealth.com (Accessed 8 December 2014).
36. Smartinhaler. http://www.smartinhaler.com (Accessed 8 December 2014).
37. Seheult JN, O'Connell P, Tee KC, Bholah T, Al Bannai H, Sulaiman I et al. The acoustic features of inhalation can be used to quantify aerosol delivery from a Diskus dry powder inhaler. Pharm Res 2014; 31: 2735-2747.
38. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-907.
39. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65.
40. Rodriguez KL, Burkitt KH, Bayliss NK, Skoko JE, Switzer GE, Zickmund SL et al. Veteran, primary care provider, and specialist satisfaction with electronic consultation. JMIR Med Inform 2015; 3: e5.
41. Thomas M. Why aren't we doing better in asthma: time for personalised medicine? NPJ Prim Care Respir Med 2015; 25: 15004.
42. Wisnivesky JP, Krauskopf K, Wolf MS, Wilson EA, Sofianou A, Martynenko M et al. The association between language proficiency and outcomes of elderly patients with asthma. Ann Allergy Asthma Immunol 2012; 109: 179-184.
43. Talreja N, Soubani AO, Sherwin RL, Baptist AP. Modifiable factors associated with severe asthma exacerbations in urban patients. Ann Allergy Asthma Immunol 2012; 109: 128-132.
44. McGillicuddy JW, Weiland AK, Frenzel RM, Mueller M, Brunner-Jackson BM, Taber DJ et al. Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res 2013; 15: e6.
45. Joubert A, Kidd-Taylor A, Christopher G, Nanda J, Warren R, Lindong I et al. Complementary and alternative medical practice: self-care preferred vs. practitioner-based care among patients with asthma. J Natl Med Assoc 2010; 102: 562-569.
46. Caress AL, Beaver K, Luker K, Campbell M, Woodcock A. Involvement in treatment decisions: what do adults with asthma want and what do they get? Results of a cross sectional survey. Thorax 2005; 60: 199-205.
47. Ostrem A, Horne R. Reducing asthma attacks: consider patients' beliefs. NPJ Prim Care Respir Med 2015; 25: 15021.
48. Shah S, Peat JK, Mazurski EJ, Wang H, Sindhusake D, Bruce C et al. Effect of peer led programme for asthma education in adolescents: cluster randomised controlled trial. BMJ 2001; 322: 583-585.
49. Rhee H, McQuillan BE, Belyea MJ. Evaluation of a peer-led asthma selfmanagement program and benefits of the program for adolescent peer leaders. Respir Care 2012; 57: 2082-2089.
50. Rhee H, Pesis-Katz I, Xing J. Cost benefits of a peer-led asthma self-management program for adolescents. J Asthma 2012; 49: 606-613.
51. Duplaga M. The acceptance of e-health solutions among patients with chronic respiratory conditions. Telemed J E Health 2013; 19: 683-691.
52. Harnett CM, Hunt EB, Bowen BR, O'Connell OJ, Edgeworth DM, Mitchell P et al. A study to assess inhaler technique and its potential impact on asthma control in patients attending an asthma clinic. J Asthma 2014; 51: 440-445.
53. Horner SD, Brown A. Evaluating the effect of an asthma self-management intervention for rural families. J Asthma 2014; 51: 168-177.
54. Ryan D, Murphy A, Stallberg B, Baxter N, Heaney LG. 'SIMPLES': a structured primary care approach to adults with difficult asthma. Prim Care Respir J 2013; 22: 365-373.
55. Agusti A, Anto JM, Auffray C, Barbe F, Barreiro E, Dorca J et al. Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med 2015; 191: 391-401.
56. Bender BG. Advancing the science of adherence measurement: implications for the clinician. J Allergy Clin Immunol Pract 2013; 1: 92-93.
57. Ryan D, Price D, Musgrave SD, Malhotra S, Lee AJ, Ayansina D et al. Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial. BMJ 2012; 344: e1756.
58. Huckvale K, Car M, Morrison C, Car J. Apps for asthma self-management: a systematic assessment of content and tools. BMC Med 2012; 10: 144.
59. Marcano Belisario JS, Huckvale K, Greenfield G, Car J, Gunn LH. Smartphone and tablet self management apps for asthma. Cochrane Database Syst Rev 2013; 11: CD010013.
60. Anhoj J, Nielsen L. Quantitative and qualitative usage data of an Internet-based asthma monitoring tool. J Med Internet Res 2004; 6: e23.
61. van Gaalen JL, Beerthuizen T, van der Meer V, van Reisen P, Redelijkheid GW, Snoeck-Stroband JB et al. Long-term outcomes of internet-based self-management support in adults with asthma: randomized controlled trial. J Med Internet Res 2013; 15: e188.
62. van der Meer V, van den Hout WB, Bakker MJ, Rabe KF, Sterk PJ, Assendelft WJ et al. Cost-effectiveness of Internet-based self-management compared with usual care in asthma. PLoS One 2011; 6: e27108.
63. Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 890-896.
64. European Innovation Partnership on Active and Healthy Ageing, Action Plan B3Mechanisms of the Development of Allergy, WP 10Global Alliance against Chronic Respiratory Diseases, Bousquet J, Addis A, Adcock I et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 2014; 44: 304-323.